XOLTAR
Behavioral & Lifestyle Health
Round Seed

50% of chronic patients fail to stick to treatments and lifestyle changes, resulting in a $650B/Yr revenue loss for pharma. XOLTAR's platform features the only AI-companion that can emulate the relationship between patients and care managers by conducting behavioral interventions over video calls with patients based on evidence-based protocols. XOLTAR also empowers pharma's support team, providing them with a dashboard to leverage the AI companions as co-pilots, scaling their support.